PUT - SPRINTER OPEN END - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 11:20:54 04/06/2024 pm IST | ||
| 9.44 EUR | -1.46% |
|
| Current month | -7.36% | ||
| 1 month | -14.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 04/24/04 | 9.44 | -1.46% |
| 03/24/03 | 9.58 | -5.99% |
| 31/24/31 | 10.19 | -5.12% |
| 30/24/30 | 10.74 | -3.07% |
| 29/24/29 | 11.08 | +2.21% |
Delayed Quote Deutsche Boerse AG
Last update June 04, 2024 at 11:20 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VV7EKK |
| ISIN | DE000VV7EKK2 |
| Date issued | 29/09/2022 |
| Strike | 332.4 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.99 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.47 € |
|---|---|
| Lowest since issue | 1.01 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
234.1
USD
Average target price
284.8
USD
Spread / Average Target
+21.63%
- Stock Market
- Certificates
- Certificat
